Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: Possible association with antifibrinolytic therapy
- 31 May 2006
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 131 (5) , 963-968
- https://doi.org/10.1016/j.jtcvs.2006.01.005
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Pharmacologic preservation of the hemostatic system during cardiac surgeryThe Annals of Thoracic Surgery, 2001
- Mechanisms and attenuation of hemostatic activation during extracorporeal circulationThe Annals of Thoracic Surgery, 2001
- Fatal Thrombosis Associated with a Hemi-Fontan Procedure, Heparin–Protamine Reversal, and AprotininAnesthesiology, 2001
- Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpointsThe Lancet, 1999
- Analyses of coronary graft patency after aprotinin use: Results from the international multicenter aprotinin graft patency experience (IMAGE) trialThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Management of Bleeding Complications in Redo Cardiac OperationsThe Annals of Thoracic Surgery, 1998
- Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose RegimensThe Annals of Thoracic Surgery, 1996
- Safety of repeat aprotinin administration for LVAD recipients undergoing cardiac transplantationThe Annals of Thoracic Surgery, 1996
- Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortalityThe Annals of Thoracic Surgery, 1995
- Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patencyThe Journal of Thoracic and Cardiovascular Surgery, 1994